Eric Harwood is a Partner at Seed IP Law Group, where he specializes in U.S. and foreign chemical patent matters, including patent procurement, licensing, and strategic portfolio management. He received a B.S. in Chemistry (summa cum laude) from the University of California, Davis (1993) and a M.S. in Organic Chemistry from the University of Washington (1997). Eric earned a Ph.D. in Organic Chemistry from the University of Washington (1999). He holds a J.D. from the University of Washington School of Law (2009). EXPERIENCE Prior to joining Seed IP as an associate, Eric served as a principal scientist at Chiron Corporation (Seattle, WA) for over six years where he helped develop HIV, cancer, diabetes, and antibacterial drug candidates. Eric’s work at Chiron included process development, cGMP synthesis, and drug discovery, as well as preparation of technology transfer documents and FDA regulatory submissions. While at the University of Washington, he developed novel synthetic methods for preparing modified nucleosides and cross-linked oligonucleotides. Eric also previously worked as a research chemist at Gilead Sciences (Foster City, CA) developing HIV protease inhibitors. Eric has co-authored multiple scientific articles published in peer-reviewed journals and is a co-inventor on several pending U.S. and foreign patent applications.